Compare CNO & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNO | LIVN |
|---|---|---|
| Founded | 1979 | 1987 |
| Country | United States | United Kingdom |
| Employees | 3300 | N/A |
| Industry | Accident &Health Insurance | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.5B |
| IPO Year | N/A | 2015 |
| Metric | CNO | LIVN |
|---|---|---|
| Price | $40.55 | $61.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 7 |
| Target Price | $46.25 | ★ $72.43 |
| AVG Volume (30 Days) | 543.4K | ★ 913.8K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.15 |
| Revenue Next Year | $3.32 | $6.67 |
| P/E Ratio | $18.71 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.24 | $32.48 |
| 52 Week High | $44.86 | $71.58 |
| Indicator | CNO | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 40.54 |
| Support Level | $38.86 | $49.51 |
| Resistance Level | $41.93 | $65.91 |
| Average True Range (ATR) | 1.08 | 2.36 |
| MACD | -0.23 | -0.99 |
| Stochastic Oscillator | 39.74 | 23.47 |
CNO Financial Group Inc is a holding company for a group of insurance companies that develop, market and administer health insurance, annuity, individual life insurance and other insurance and financial services products. Consumers are served through the phone, online, mail, face-to-face with agents, or sales channels. The company's operating segments include annuity, health, and life insurance product lines as well as the investment and fee revenue segments. Maximum revenue is generated from the health product line segment. Annuity premiums account for the majority of the total premiums collected. Annuity products include fixed index annuities, traditional fixed-rate annuities, and single-premium immediate annuity products.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.